334 related articles for article (PubMed ID: 10541436)
1. DNA priming-protein boosting enhances both antigen-specific antibody and Th1-type cellular immune responses in a murine herpes simplex virus-2 gD vaccine model.
Sin JI; Bagarazzi M; Pachuk C; Weiner DB
DNA Cell Biol; 1999 Oct; 18(10):771-9. PubMed ID: 10541436
[TBL] [Abstract][Full Text] [Related]
2. Prime-boost immunization with DNA and modified vaccinia virus ankara vectors expressing herpes simplex virus-2 glycoprotein D elicits greater specific antibody and cytokine responses than DNA vaccine alone.
Meseda CA; Elkins KL; Merchlinsky MJ; Weir JP
J Infect Dis; 2002 Oct; 186(8):1065-73. PubMed ID: 12355355
[TBL] [Abstract][Full Text] [Related]
3. IL-12 gene as a DNA vaccine adjuvant in a herpes mouse model: IL-12 enhances Th1-type CD4+ T cell-mediated protective immunity against herpes simplex virus-2 challenge.
Sin JI; Kim JJ; Arnold RL; Shroff KE; McCallus D; Pachuk C; McElhiney SP; Wolf MW; Pompa-de Bruin SJ; Higgins TJ; Ciccarelli RB; Weiner DB
J Immunol; 1999 Mar; 162(5):2912-21. PubMed ID: 10072541
[TBL] [Abstract][Full Text] [Related]
4. LFA-3 plasmid DNA enhances Ag-specific humoral- and cellular-mediated protective immunity against herpes simplex virus-2 in vivo: involvement of CD4+ T cells in protection.
Sin JI; Kim J; Dang K; Lee D; Pachuk C; Satishchandran C; Weiner DB
Cell Immunol; 2000 Jul; 203(1):19-28. PubMed ID: 10915558
[TBL] [Abstract][Full Text] [Related]
5. [Enhancement of herpes simplex virus-1 glycoprotein-D DNA vaccine induced specific immune responses by coimmunization with interleukin-2 genetic adjuvant].
Liu XJ; Zhu MZ; Song GX; Xu YF; Liu HW; Wang S; Yang BL; Dong FT; Xu XM
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Feb; 27(1):67-72. PubMed ID: 15782496
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of protective humoral (Th2) and cell-mediated (Th1) immune responses against herpes simplex virus-2 through co-delivery of granulocyte-macrophage colony-stimulating factor expression cassettes.
Sin JI; Kim JJ; Ugen KE; Ciccarelli RB; Higgins TJ; Weiner DB
Eur J Immunol; 1998 Nov; 28(11):3530-40. PubMed ID: 9842896
[TBL] [Abstract][Full Text] [Related]
7. Modulation of cellular responses by plasmid CD40L: CD40L plasmid vectors enhance antigen-specific helper T cell type 1 CD4+ T cell-mediated protective immunity against herpes simplex virus type 2 in vivo.
Sin JI; Kim JJ; Zhang D; Weiner DB
Hum Gene Ther; 2001 Jun; 12(9):1091-102. PubMed ID: 11399230
[TBL] [Abstract][Full Text] [Related]
8. Improved immunogenicity of a tuberculosis DNA vaccine encoding ESAT6 by DNA priming and protein boosting.
Wang QM; Sun SH; Hu ZL; Yin M; Xiao CJ; Zhang JC
Vaccine; 2004 Sep; 22(27-28):3622-7. PubMed ID: 15315841
[TBL] [Abstract][Full Text] [Related]
9. Plasmid DNA-expressed secreted and nonsecreted forms of herpes simplex virus glycoprotein D2 induce different types of immune responses.
Higgins TJ; Herold KM; Arnold RL; McElhiney SP; Shroff KE; Pachuk CJ
J Infect Dis; 2000 Nov; 182(5):1311-20. PubMed ID: 11023455
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant use of the NKT cell agonist alpha-galactosylceramide leads to enhancement of M2-based DNA vaccine immunogenicity and protective immunity against influenza A virus.
Fotouhi F; Shaffifar M; Farahmand B; Shirian S; Saeidi M; Tabarraei A; Gorji A; Ghaemi A
Arch Virol; 2017 May; 162(5):1251-1260. PubMed ID: 28120096
[TBL] [Abstract][Full Text] [Related]
11. Development of Th1 and Th2 populations and the nature of immune responses to hepatitis B virus DNA vaccines can be modulated by codelivery of various cytokine genes.
Chow YH; Chiang BL; Lee YL; Chi WK; Lin WC; Chen YT; Tao MH
J Immunol; 1998 Feb; 160(3):1320-9. PubMed ID: 9570550
[TBL] [Abstract][Full Text] [Related]
12. Antibody responses, cytokine levels and protection of mice immunised with HSV-2 antigens formulated into NISV or ISCOM delivery systems.
Mohamedi SA; Brewer JM; Alexander J; Heath AW; Jennings R
Vaccine; 2000 Apr; 18(20):2083-94. PubMed ID: 10715522
[TBL] [Abstract][Full Text] [Related]
13. Prophylactic herpes simplex virus type 2 vaccine adjuvanted with a universal CD4 T cell helper peptide induces long-term protective immunity against lethal challenge in mice.
Li X; Zhang S; Lei J; Zhu Y; Zhou X; Xiao J; Xiang T
Int Immunopharmacol; 2018 Aug; 61():100-108. PubMed ID: 29857239
[TBL] [Abstract][Full Text] [Related]
14. In vivo modulation of vaccine-induced immune responses toward a Th1 phenotype increases potency and vaccine effectiveness in a herpes simplex virus type 2 mouse model.
Sin JI; Kim JJ; Boyer JD; Ciccarelli RB; Higgins TJ; Weiner DB
J Virol; 1999 Jan; 73(1):501-9. PubMed ID: 9847356
[TBL] [Abstract][Full Text] [Related]
15. Immunopotentiation of DNA vaccine against herpes simplex virus via co-delivery of plasmid DNA expressing CCR7 ligands.
Eo SK; Lee S; Kumaraguru U; Rouse BT
Vaccine; 2001 Sep; 19(32):4685-93. PubMed ID: 11535317
[TBL] [Abstract][Full Text] [Related]
16. Studies on antibody responses following neonatal immunization with influenza hemagglutinin DNA or protein.
Pertmer TM; Robinson HL
Virology; 1999 May; 257(2):406-14. PubMed ID: 10329551
[TBL] [Abstract][Full Text] [Related]
17. Coexpression of interleukin-2 enhances the immunization effect of a DNA vaccine expressing herpes simplex 1 glycoprotein D.
Li WR; Niu B; Wang JW; Feng ZJ; Wang DX
Acta Virol; 2006; 50(4):251-6. PubMed ID: 17177610
[TBL] [Abstract][Full Text] [Related]
18. A DNA-prime/protein-boost vaccination regimen enhances Th2 immune responses but not protection following Schistosoma mansoni infection.
Da'Dara AA; Skelly PJ; Walker CM; Harn DA
Parasite Immunol; 2003; 25(8-9):429-37. PubMed ID: 14651590
[TBL] [Abstract][Full Text] [Related]
19. A novel adjuvant, the general opioid antagonist naloxone, elicits a robust cellular immune response for a DNA vaccine.
Jamali A; Mahdavi M; Hassan ZM; Sabahi F; Farsani MJ; Bamdad T; Soleimanjahi H; Motazakker M; Shahabi S
Int Immunol; 2009 Mar; 21(3):217-25. PubMed ID: 19174474
[TBL] [Abstract][Full Text] [Related]
20. An ocular mucosal administration of nanoparticles containing DNA vaccine pRSC-gD-IL-21 confers protection against mucosal challenge with herpes simplex virus type 1 in mice.
Hu K; Dou J; Yu F; He X; Yuan X; Wang Y; Liu C; Gu N
Vaccine; 2011 Feb; 29(7):1455-62. PubMed ID: 21185849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
